ResearchSafe

Apollo Stack vs Performance Stack

A side-by-side research comparison of Apollo Stack and Performance Stack across mechanism, dosing, half-life, benefits, side effects and research status.

Comparison table

AttributeApollo StackPerformance Stack
Full nameApollo (Semaglutide + 5-Amino-1MQ + MOTS-c + Tesamorelin)Performance (Follistatin-344 + IGF-1 LR3 + MGF + CJC/Ipa)
CategoryPopular StacksPopular Stacks
StatusResearch stackResearch stack
MechanismSemaglutide activates GLP-1 receptors for appetite/glucose control. 5-Amino-1MQ inhibits NNMT to boost NAD+ and cellular energy. MOTS-c activates AMPK like exercise. Tesamorelin specifically targets visceral fat through GH-mediated lipolysis.Follistatin-344 binds and neutralizes myostatin, removing the genetic brake on muscle growth. IGF-1 LR3 activates Akt/mTOR for protein synthesis. MGF activates dormant satellite cells for muscle fiber addition. CJC-1295/Ipamorelin provides GH support for recovery and fat oxidation.
Molecular weightMultiple compoundsMultiple compounds
Half-lifeSemaglutide: ~7 days, 5A1MQ: ~6h, MOTS-c: ~4h, Tesamorelin: ~30minFollistatin: ~2-4h, IGF-1 LR3: ~20-30h, MGF: ~5-7min, CJC/Ipa: ~30min/2h
BioavailabilityVariable by componentAll injectable: ~90-95% SC/IM
Typical doseSema 0.25-2.4mg/wk + 5A1MQ 100mg 2x/day + MOTS-c 10mg 3x/wk + Tesa 2mg/dayFollistatin 100mcg + IGF-1 LR3 50mcg + MGF 200mcg post-workout + CJC 100mcg/Ipa 200mcg nightly
FrequencyVariable by componentDaily/post-workout
RouteSC injection + OralSubcutaneous/Intramuscular injection

Apollo Stack reported benefits

  • Dramatic fat loss
  • Visceral fat reduction
  • Metabolic rate increase
  • Appetite control
  • Improved insulin sensitivity
  • Cellular energy boost

Performance Stack reported benefits

  • Myostatin inhibition
  • Enhanced protein synthesis
  • Satellite cell activation
  • Accelerated recovery
  • Increased strength
  • Lean mass gains

Related comparisons

Research and educational reference only. Not medical advice.